Skip to main content

Table 2 Comparison of our study results with the natural history of ONFH and outcomes of other treatments

From: Ten-year results of concentrated autologous bone marrow aspirate transplantation for osteonecrosis of the femoral head: a retrospective study

  Treatment Number of hips Follow-up period (years) Collapse Rate (%) THA -conversion rate (%)
this study CDa + BMCb 80 12 60% (20/33) 34% (27/80)
Hernigou P 2006 [21] natural history 121 14 77% (93/121) 75% (91/121)
Nam KW 2008 [22] 105 8.6 59% (62/105) 44% (46/105)
Koo KH 1995 [20] 19 2 79% (15/19) 68% (13/19)
Learmonth ID 1990 [23] CDa 41 2.6 83% (34/41)
Gangji V 2011 [7] 11 5 73% (8/11) 27% (3/11)
Koo KH 1995 [20] 18 2 72% (13/18) 72% (13/18)
Hernigou P 2009 [6] CDa + BMCb 534 13 30% (160/534) 18% (96/534)
Hernigou P 2002 [5] 189 7 18% (34/189)
Gangji V 2011 [7] 13 5 23% (3/13)
Kuroda Y 2016 [18] gelatin hydrogel + FGFc 10 1 10% (1/10) 0% (0/10)
Lieberman JR 2004 [24] CDb + fibula allograft + BMPd 17 4.4 18% (3/17) 18% (3/17)
Mont A 1996 [25] osteotomy 77 11.5 24%
Sugioka Y 1978 [26] 41 2.5 6% (stage 1, 2)
  1. (ONFH-osteonecrosis of the femoral head, aCD Core decompression, bBMC Bone marrow concentrate, c FGF Fibroblast growth factor, dBMP Bone morphogenetic protein)